JCX-40-21 (September 11, 2021)
Description Of Subtitle J – Drug Pricing: Budget Reconciliation Legislative Recommendations
The staff of the Joint Committee on Taxation provides descriptions of the provisions included in subtitle J, the proposed budget reconciliation legislative recommendations relating to prescription drug pricing, scheduled for consideration by the House Committee on Ways and Means, Tuesday, September 14, 2021.
The staff of the Joint Committee on Taxation provides descriptions of the provisions included in subtitle J, the proposed budget reconciliation legislative recommendations relating to prescription drug pricing, scheduled for consideration by the House Committee on Ways and Means, Tuesday, September 14, 2021.
Related Publications
-
JCX-44-23 (September 27, 2023)
Description Of The Chairman’s Amendment In The Nature Of A Substitute To H.R. 5687, The “HSA Modernization Act Of 2023”
view details -
JCX-43-23 (September 27, 2023)
Description Of The Chairman’s Amendment In The Nature Of A Substitute To H.R. 5688, The “Bipartisan HSA Improvement Act Of 2023”
view details -
JCX-42-23 (September 26, 2023)
Estimated Revenue Effects Of H.R. 5687, The “HSA Modernization Act Of 2023,” Scheduled For Markup By The Committee On Ways And Means On September 28, 2023
view details